Insider: MCKINLEY THOMAS Director - Teladoc Health, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 39,077 | 0 | 39,077 |
| Value | $198,706.55 | $0.00 | $198,706.55 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/12/2024 | AAP | 4,000 | Direct | COM | $7.69 | $30,756.00 | 39,077 |
| 08/07/2024 | AAP | 4,000 | Direct | COM | $7.19 | $28,756.00 | 35,077 |
| 08/06/2024 | AAP | 7,000 | Direct | COM | $7.57 | $52,990.00 | 31,077 |
| 06/04/2020 | DDS | 4,695 | Direct | COM | $163.00 | $765,285.00 | 4,830 |
| 06/03/2020 | DDS | 12,093 | Direct | COM | $166.79 | $2,016,991.47 | 9,525 |
| 04/16/2020 | DDS | 40,000 | Direct | COM | $169.64 | $6,785,600.00 | 6,513 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research